These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 8442772

  • 1. Inhibition of low density lipoprotein oxidation by thyronines and probucol.
    Hanna AN, Feller DR, Witiak DT, Newman HA.
    Biochem Pharmacol; 1993 Feb 09; 45(3):753-62. PubMed ID: 8442772
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Probucol inhibits oxidative modification of low density lipoprotein.
    Parthasarathy S, Young SG, Witztum JL, Pittman RC, Steinberg D.
    J Clin Invest; 1986 Feb 09; 77(2):641-4. PubMed ID: 3944273
    [Abstract] [Full Text] [Related]

  • 7. Dipyridamole inhibits the oxidative modification of low density lipoprotein.
    Selley ML, Czeti AL, McGuiness JA, Ardlie NG.
    Atherosclerosis; 1994 Nov 09; 111(1):91-7. PubMed ID: 7840817
    [Abstract] [Full Text] [Related]

  • 8. Novel 3,5-diaryl pyrazolines and pyrazole as low-density lipoprotein (LDL) oxidation inhibitor.
    Jeong TS, Kim KS, Kim JR, Cho KH, Lee S, Lee WS.
    Bioorg Med Chem Lett; 2004 Jun 07; 14(11):2719-23. PubMed ID: 15125921
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Differing effects of probucol and vitamin E on the oxidation of lipoproteins, ceroid accumulation and protein uptake by macrophages.
    Hunt JV, Bottoms MA, Taylor SE, Lyell V, Mitchinson MJ.
    Free Radic Res; 1994 Mar 07; 20(3):189-201. PubMed ID: 8019642
    [Abstract] [Full Text] [Related]

  • 12. Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification.
    Jialal I, Grundy SM.
    J Clin Invest; 1991 Feb 07; 87(2):597-601. PubMed ID: 1991843
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Concentration-dependent antioxidant activity of probucol in low density lipoproteins in vitro: probucol degradation precedes lipoprotein oxidation.
    Barnhart RL, Busch SJ, Jackson RL.
    J Lipid Res; 1989 Nov 07; 30(11):1703-10. PubMed ID: 2614272
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Melatonin inhibits oxidative modification of human low-density lipoprotein.
    Kelly MR, Loo G.
    J Pineal Res; 1997 May 07; 22(4):203-9. PubMed ID: 9247205
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of iodotyrosines, thyronines, iodothyroacetic acids and thyromimetic analogues on in vitro copper-induced oxidation of low-density lipoproteins.
    Chomard P, Seguin C, Loireau A, Autissier N, Artur Y.
    Biochem Pharmacol; 1998 May 15; 55(10):1591-601. PubMed ID: 9633995
    [Abstract] [Full Text] [Related]

  • 19. Effect of probucol treatment on the susceptibility of low density lipoprotein isolated from hypercholesterolemic patients to become oxidatively modified in vitro.
    Regnström J, Walldius G, Carlson LA, Nilsson J.
    Atherosclerosis; 1990 May 15; 82(1-2):43-51. PubMed ID: 2360919
    [Abstract] [Full Text] [Related]

  • 20. Antioxidant BO-653 and human macrophage-mediated LDL oxidation.
    Müller K, Carpenter KL, Freeman MA, Mitchinson MJ.
    Free Radic Res; 1999 Jan 15; 30(1):59-71. PubMed ID: 10193574
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.